Protai Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $20M

  • Investors
  • 4

Protai Bio General Information

Description

Developer of a proteomics-centered AI-powered platform designed to improve the way new drugs are discovered. The company's platform uses mass spectrometry proteomics, other protein-oriented datasets and machine learning models to identify proteo-forms, including post-translational modifications, protein-protein interactions, and quantification that reshape the outcome of complex diseases, enabling researchers to unlock complex biological insights in drug development and improve every process while lowering costs.

Contact Information

Website
www.protai.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Shoham 5
  • Street 4
  • Ramat Gan
  • Israel
+972
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • Shoham 5
  • Street 4
  • Ramat Gan
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Protai Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 15-Mar-2023 $20M Completed Generating Revenue
1. Accelerator/Incubator 14-Oct-2022 Completed Startup
To view Protai Bio’s complete valuation and funding history, request access »

Protai Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a proteomics-centered AI-powered platform designed to improve the way new drugs are discovered. The company
Discovery Tools (Healthcare)
Ramat Gan, Israel
28 As of 2026

Boston, MA
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Protai Bio Competitors (9)

One of Protai Bio’s 9 competitors is Manifold Bio, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Manifold Bio Venture Capital-Backed Boston, MA
LabGenius Therapeutics Venture Capital-Backed London, United Kingdom
ProteinQure Venture Capital-Backed Toronto, Canada
BigHat Biosciences Venture Capital-Backed San Mateo, CA
Ordaos Venture Capital-Backed New York, NY
You’re viewing 5 of 9 competitors. Get the full list »

Protai Bio Patents

Protai Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026167419-A1 Compounds for lysine acetyltransferase 6 (kat6) inhibition and therapeutic applications thereof Pending 04-Feb-2025

Protai Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Protai Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Grove Ventures Venture Capital Minority
Maj Invest PE/Buyout Minority
Pitango Venture Capital Venture Capital Minority
Endless Frontier Labs Accelerator/Incubator Minority
To view Protai Bio’s complete investors history, request access »

Protai Bio FAQs

  • When was Protai Bio founded?

    Protai Bio was founded in 2021.

  • Where is Protai Bio headquartered?

    Protai Bio is headquartered in Ramat Gan, Israel.

  • What is the size of Protai Bio?

    Protai Bio has 28 total employees.

  • What industry is Protai Bio in?

    Protai Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Protai Bio a private or public company?

    Protai Bio is a Private company.

  • What is Protai Bio’s current revenue?

    The current revenue for Protai Bio is .

  • How much funding has Protai Bio raised over time?

    Protai Bio has raised $20M.

  • Who are Protai Bio’s investors?

    Grove Ventures, Maj Invest, Pitango Venture Capital, and Endless Frontier Labs have invested in Protai Bio.

  • Who are Protai Bio’s competitors?

    Manifold Bio, LabGenius Therapeutics, ProteinQure, BigHat Biosciences, and Ordaos are some of the 9 competitors of Protai Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process